# Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

> **NCT04529538** · PHASE1 · COMPLETED · sponsor: **PATH** · enrollment: 226 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Novel Oral Polio Vaccine Type 1 (nOPV1)
- **BIOLOGICAL:** Novel Oral Polio Vaccine Type 3 (nOPV3)
- **BIOLOGICAL:** Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1)
- **BIOLOGICAL:** Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3)

## Key facts

- **NCT ID:** NCT04529538
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-26
- **Primary completion:** 2023-02-17
- **Final completion:** 2023-02-17
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2024-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529538, "Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04529538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*